New drug listed on PBS for psoriatic arthritis
Tofacitinib (sold as Xeljanz), is already available on the Pharmaceutical Benefits Scheme (PBS), but will be extended to include treatment of patients with psoriatic arthritis. More than 4800 patients are expected to benefit from the subsidy, which will allow them to access the medicine for $40.30 per script, or...
Private health insurance reforms – what are the changes and how will they affect you?
If you have private health insurance, or are considering getting it, you should be aware of a series of changes that have come into effect on April 1 2019. These include the annual premium increase, a small decrease in rebates, the introduction of a new tiered system designed to...
Subscribe to our mailing list
Our free eNewsletter keeps you up-to-date on information about managing your condition, our programs and the latest news & research about arthritis and other musculoskeletal conditions.
